A detailed history of Arrowstreet Capital, Limited Partnership transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 225,020 shares of EW stock, worth $15 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
225,020
Previous 857,006 73.74%
Holding current value
$15 Million
Previous $81.9 Million 74.62%
% of portfolio
0.02%
Previous 0.08%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $53.3 Million - $59.6 Million
-631,986 Reduced 73.74%
225,020 $20.8 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $14.9 Million - $19.6 Million
-204,778 Reduced 19.29%
857,006 $81.9 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $24.1 Million - $30.3 Million
-389,815 Reduced 26.85%
1,061,784 $81 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $45.2 Million - $60.9 Million
-652,500 Reduced 31.01%
1,451,599 $101 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $347,946 - $403,166
-4,274 Reduced 0.2%
2,104,099 $198 Million
Q1 2023

May 15, 2023

SELL
$74.26 - $84.51 $46.1 Million - $52.5 Million
-620,906 Reduced 22.75%
2,108,373 $174 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $20.4 Million - $26.1 Million
298,351 Added 12.27%
2,729,279 $204 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $30.1 Million - $39.2 Million
-365,613 Reduced 13.07%
2,430,928 $201 Million
Q2 2022

Aug 15, 2022

SELL
$86.5 - $128.27 $44.6 Million - $66.1 Million
-515,592 Reduced 15.57%
2,796,541 $266 Million
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $5.21 Million - $6.56 Million
51,140 Added 1.57%
3,312,133 $390 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $75.4 Million - $92.6 Million
708,921 Added 27.78%
3,260,993 $422 Million
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $111 Million - $132 Million
1,074,538 Added 72.73%
2,552,072 $289 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $42.9 Million - $53.7 Million
512,265 Added 53.07%
1,477,534 $153 Million
Q1 2021

May 14, 2021

BUY
$78.68 - $90.67 $74.1 Million - $85.4 Million
941,850 Added 4021.73%
965,269 $80.7 Million
Q4 2020

Feb 12, 2021

SELL
$71.69 - $91.23 $17.4 Million - $22.1 Million
-242,661 Reduced 91.2%
23,419 $2.14 Million
Q3 2020

Nov 12, 2020

SELL
$67.19 - $87.44 $106 Million - $138 Million
-1,572,792 Reduced 85.53%
266,080 $21.2 Million
Q2 2020

Aug 12, 2020

BUY
$57.54 - $76.95 $58.4 Million - $78.1 Million
1,015,022 Added 123.2%
1,838,872 $127 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $14.6 Million - $22.5 Million
278,114 Added 50.96%
823,850 $155 Million
Q4 2019

Feb 13, 2020

BUY
$71.7 - $82.09 $39.1 Million - $44.8 Million
545,736 New
545,736 $127 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $1.45 Million - $1.78 Million
-23,593 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $5.32 Million - $6.14 Million
-95,387 Reduced 80.17%
23,593 $4.36 Million
Q1 2019

May 15, 2019

BUY
$47.89 - $64.05 $4.44 Million - $5.94 Million
92,675 Added 352.31%
118,980 $22.8 Million
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $21.9 Million - $26.9 Million
-471,811 Reduced 94.72%
26,305 $4.03 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $3.04 Million - $3.86 Million
66,589 Added 15.43%
498,116 $86.7 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $4.55 Million - $5.5 Million
107,289 Added 33.09%
431,527 $62.8 Million
Q1 2018

May 14, 2018

BUY
$37.19 - $47.45 $7.81 Million - $9.97 Million
210,106 Added 184.09%
324,238 $45.2 Million
Q4 2017

Feb 09, 2018

SELL
$33.79 - $39.39 $15.8 Million - $18.4 Million
-467,910 Reduced 80.39%
114,132 $12.9 Million
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $21.1 Million - $22.6 Million
582,042
582,042 $63.6 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.